MedTrace Logo

Early Adjuvant Diagnosis of Pulmonary Nodules Based on CTC.

NCT06187935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2025-02-27

No results posted yet for this study

Summary

The goal of this observational clinical trial is to evaluate the value of circulating tumor cell detection in the early diagnosis of malignant pulmonary nodule. The main questions it aims to answer is: the sensitivity and specificity of peripheral blood circulating tumor cell detection in differentiating benign and malignant pulmonary nodules (≤3cm). Participants will be asked provide 4mL of peripheral blood for the test.

Conditions

  • Pulmonary Nodules, Solitary
  • Pulmonary Nodules, Multiple

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Principal Investigators

  • Guangying Zhu, M.D. · China-Japan Friendship Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06187935 on ClinicalTrials.gov